Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
15 Results Found
CDC investigating counterfeit, mishandled botulinum toxin injections
The Centers for Disease Control and Prevention and Food and Drug Administration are investigating adverse effects in 22 people in 11 states who received botulinum toxin injections that were counterfeit or administered in non-healthcare settings or by unlicensed or untrained individuals.
CDC alerts clinicians to increase in drug-resistant Shigellosis infections
The Centers for Disease Control and Prevention today advised clinicians to report extensively drug-resistant strains of Shigella infections to their state or local health department, and educate patients and communities at increased risk.
Report calls for action to prevent infection disparities for dialysis patients
Adults receiving dialysis treatment for end-stage kidney disease were 100 times more likely to have a Staphylococcus aureus bloodstream infection than adults not on dialysis during 2017-2020, with the risk 40% higher for Hispanic patients than white patients, according to a report released today by the Centers for Disease Control and Prevention.
AHA Leadership Summit Roundtable: The Future of Health Care Quality
A Quality Leadership Roundtable that took place at the 2022 American Hospital Association Leadership Summit in San Diego. Hosted by the AHA Living Learning Network.
AHA, AHRQ release toolkit to help hospitals prevent ICU infections
The customizable toolkit offers resources to help prevent central line-associated bloodstream infections and catheter-associated urinary tract infections.
CDC issues guidance on treating drug-resistant typhoid fever
The Centers for Disease Control and Prevention released recommendations for treating Extensively Drug-Resistant Salmonella Typhi, a systemic illness transmitted through contaminated food and water and person-to-person contact.
FDA announces voluntary tetracycline recall
The Food and Drug Administration recently announced that Avet Pharmaceuticals Inc. issued a voluntary recall of the antibiotic, tetracycline, specifically, Tetracycline HCl Capsules USP, 250 mg and 500 mg, distributed under the Heritage Pharmaceuticals Inc. label.
AHRQ: Hospital acquired-conditions decline by nearly 1 million
Hospital-acquired conditions declined by 13 percent between 2014 and 2017, preventing an estimated 20,500 deaths and $7.7 billion in health care costs, according to preliminary
AHRQ: HACs declined 17% from 2010 to 2014
Hospitals are making “substantial progress in improving safety,” according to a new report fr
CMS alerts hospitals to error in HAC hospital-specific reports
The Centers for Medicare & Medicare Services today